Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09KRE
|
|||
| Drug Name |
Bezlotoxumab
|
|||
| Synonyms |
CDB1; Clostridium difficile toxin B monoclonal antibody; MBL-CDB1; MDX-1388; MK 6072; Zinplava
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | C. difficile infection [ICD-11: 1A04; ICD-10: A00-B99] | Approved | [1] | |
| Company |
Merck & Co.
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Clostridium difficile Toxin B (CD toxB) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.